Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Filgrastim for Prevention of Grade 4 Neutropenia in HIV Patients
NCT00002126Phase 2Completed
- Sponsor
- Amgen
- Modality
- Cytokines & Interferons
- Countries
- 2
01
Overview
A Phase 2 trial of filgrastim in neutropenia, sponsored by Amgen. Status: completed.
02
Drugs
filgrastim
03
Conditions
neutropenia
Beyond the preview
Go deeper on NCT00002126.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00002126.